Back to Search
JESUS BERDEJA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1902842412IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
43220(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1994
Research & Publications (6)
Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab.
PMID 17438098·Clin Cancer Res·2007
8-other
Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma.
PMID 16704172·Cancer Treat Res·2006
6-review
Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
PMID 16625093·Am J Surg Pathol·2006
8-other
Immunotherapy of lymphoma: update and review of the literature.
PMID 12960517·Curr Opin Oncol·2003
6-review
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma.
PMID 11760088·Biol Blood Marrow Transplant·2001
3-trial
New approaches to blood and marrow transplantation for patients with low-grade lymphomas.
PMID 11555709·Curr Opin Oncol·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 250 25TH AVE N, STE 412
NASHVILLE, TN 37203 - Phone
- (615) 986-7000
Quick Facts
- NPI
- 1902842412
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 6
Are you this provider?
Claim Your Profile